Skip to main content

Infantile Fibrosarcoma

  • Chapter
  • First Online:
Soft Tissue Tumors
  • 92 Accesses

Abstract

Infantile fibrosarcoma is a malignant tumor originating from fibroblasts. Histologically it resembles adult fibrosarcoma but shows distinctive epidemiological, molecular, and prognostic characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    ETV6-NTRK3 fusion gene: ETV6 encodes an ETS family transcription factor associated with leukemia and congenital fibrosarcoma. NTRK3 encodes neurotrophic receptor tyrosine kinase 3 and belongs to the tropomyosin receptor kinases (TRK) family which also includes NTRK1 (encoding neurotrophic receptor tyrosine kinase 1) and NTRK2 (neurotrophic receptor tyrosine kinase 2). The encoded proteins elicit activities that regulate the natural growth, differentiation, and survival of neurons when they interact with endogenous neurotrophin ligands. Chromosomal rearrangements involving in-frame fusions of these genes with various partners, translocations in the TRK kinase domains, mutations in the TRK ligand-binding site, amplifications of NTRK, or the expression of TRK splice variants can result in constitutively activated chimeric TRK fusion proteins that can act as oncogenic drivers that promote cell proliferation and survival in tumor cell lines.

  2. 2.

    Larotrectinib: tyrosine kinase inhibitor targeting the following: NTRK1, NTRK2, NTRK3.

  3. 3.

    Entrectinib: tyrosine kinase inhibitor targeting the following: NTRK1, NTRK2, NTRK3, ROS1, ALK.

Suggested Readings

  • Fletcher (2020) WHO classification of tumours of soft tissue and bone, 5th ed.

    Google Scholar 

  • Hung (2018) Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73(4):634–644

    Article  Google Scholar 

  • Kheder (2018) emerging targeted therapy for tumors with NTRK Fusion Proteins. Clin Cancer Res 24(23):5807–5814

    Article  CAS  Google Scholar 

  • Marchiò (2019) ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol 2019 [Epub ahead of print]

    Google Scholar 

  • Orbach (2016) Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. Eur J Cancer 57:1–9

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Mocellin .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mocellin, S. (2021). Infantile Fibrosarcoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_130

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-58710-9_130

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-58709-3

  • Online ISBN: 978-3-030-58710-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics